A respiratory epithelial adenomatoid hamartoma (REAH) is an uncommon benign lesion often found in the sinonasal tract. We present a case of bilateral REAH originating from the anterior olfactory cleft treated with endoscopic surgical resection without recurrence. We highlight the characteristics of REAH and necessary steps to ensure proper diagnosis and treatment.
A respiratory epithelial adenomatoid hamartoma (REAH) is a hamartoma arising from the nasal cavity, paranasal sinuses, or nasopharynx (1) . REAH was fi rst described in 1995 by Wenig and Heff ner (2) . Since then, at least 394 cases of REAH have been reported, with a 3:2 male-to-female ratio (3) . REAH displays distinct histopathological features characterized by polyps with pseudoglandular proliferation lined by ciliated respiratory epithelium (4) . Th e etiology of REAH is unknown and appears to be multifactorial (4) . Most reports indicate that REAH occurs in the presence of sinonasal infl ammation (1-3, 5, 6) . Presenting signs and symptoms include nasal obstruction, nasal congestion, deviated septum, epistaxis, rhinorrhea, chronic sinusitis, facial pain, headache, and olfactory dysfunction (7, 8) . Complete surgical resection is the preferred treatment (8) . We present a case of bilateral REAH originating from the anterior olfactory clefts.
CASE DESCRIPTION
A 75-year-old man was referred to the otorhinolaryngology department due to anosmia. He reported 10/10 loss of sense of smell that began in the early 1990s. He denied additional nasal symptoms. His medical history was signifi cant for progressive dementia, coronary artery disease, and a cerebrovascular accident 3 years prior.
Diagnostic endoscopy revealed bilateral masses in both the right and left anterior olfactory clefts, with a larger right mass than left. Magnetic resonance imaging (MRI) of the skull base demonstrated heterogeneity of the mass with enhancement, fi ndings not suggestive of simple nasal polyposis (Figure 1 ). Th e patient was taken to the operating room and underwent endoscopic resection of the lesions. Both lesions had lateralized the middle turbinate, allowing direct access and complete removal endoscopically without complications. Th e lesions appeared to be fi brous polyps on gross examination and were easily resected with Blakesley forceps. Approximately 20 cc of blood loss occurred during the resection. Histologically, both right and left nasal contents revealed infl amed polypoid fragments of respiratory mucosa with features consistent with REAH (Figure 2) . At 2-and 14-month follow-up, there was no recurrence of REAH bilaterally, as verifi ed by diagnostic endoscopy, and our patient 
One of the most common presenting symptoms of REAH is hyposmia or anosmia (8) . Th is is likely caused by local impingement or loss of olfactory nerves within the aff ected olfactory clefts. In one study, the prevalence of anosmia among participants diagnosed with REAH dropped from 72% to 44% with surgical resection (12) . Our patient had no changes to his anosmia after surgery. His history of dementia and length of symptoms may have played an independent role in his anosmia and the lack of improvement in his olfaction despite adequate resection of the hamartomas. To date, there are no reported studies investigating the relationship between the duration of anosmia and postoperative olfactory outcomes in patients with REAH.
It is important to diff erentiate REAH from more aggressive tumors to avoid excessive surgical intervention. In one retrospective study of REAH surgical subjects, no diff erence was noted in outcomes between standard endoscopic sinus surgery and aggressive resection with subperiosteal dissection and drilling into the adjacent bone (8) . Along with a computed tomography scan and MRI with contrast medium to evaluate the site and the extent and features of the lesion(s), some have recommended a preoperative biopsy in cases of a unilateral lesion or widening of the olfactory cleft (1-3, 8, 15 ). Appropriate caution should be taken when considering the diff erential of olfactory cleft masses to minimize surgical risks to patients. While there is insuffi cient evidence tracking the recurrence of REAH, available data have shown no benefi t in preventing recurrence with more aggressive removal, including subperiosteal dissection (8) . Standard endoscopic resection without subperiosteal involvement was performed to remove REAH from our patient, and there has been no evidence of recurrence on endoscopy in a 14-month postoperative period or by MRI in a 27-month period.
reported no improvement of olfaction. MRI of the brain for unrelated reasons 27 months postoperatively revealed no evidence of recurrence.
DISCUSSION
Th e histopathological features of REAH are dominated by a polypoid pseudoglandular proliferation (4). Th ese characteristics include widely spaced, small-to medium-sized pseudoglands that invaginate directly into the submucosa and are separated by stroma tissue. Th e glands are round to oval and are composed of multilayered ciliated respiratory epithelium (3). Th ese features were identifi ed in the lesions resected from the bilateral olfactory clefts of our patient (Figure 2) .
When REAH was fi rst described in 1995, it was considered extremely rare and isolated (2) . We now know that REAH is not as uncommon as originally thought and is often present with other infl ammatory processes (3). In a case series, 73% of 45 patients with REAH had an additional associated pathological process, most commonly nasal polyposis (NP) (9) . Recent studies have shown that REAH was found in 35% to 47% of patients with NP who were treated surgically (10) (11) (12) . Supporting the hypothesis of an infl ammatory pathogenic mechanism, Gu et al identifi ed signifi cantly higher levels of T-helper cells (Th 9) that secrete a proinfl ammatory cytokine IL-9 in REAH patients versus controls. Th ey suggested that Th 9 cells may play a signifi cant role in the development of REAH (13) . One prospective study suggested that those with a ≥10-year history of NP, patients requiring more than one NP-related surgery, and patients with NP and a comorbidity of asthma have an increased 
